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Field evaluation of a malaria rapid diagnostic test (ICT Pf)
Devanand Moonasar, Ameena E Goga, Philip S Kruger, Christine La Cock, Rajendra Maharaj, John Frean, Daniel Chandramohan
Malaria can be diagnosed using several approaches including 
clinical presumptive diagnosis, microscopy, polymerase 
chain reaction (PCR), enzyme-linked immunosorbent assay 
(ELISA) and malaria rapid diagnostic tests (MRDTs),1 of which 
microscopy remains the ‘gold standard’.2 Since microscopy 
requires highly skilled staff, electricity, microscopes and 
laboratory reagents, its use is restricted to appropriately 
equipped and staffed laboratories. In district primary health 
care settings, RDTs are more appropriate for diagnosis 
because they are easy to use and inexpensive, as electricity or 
highly skilled staff are not needed.1 Three key factors affect 
the accuracy of RDTs: manufacturing standards, end user 
proficiency in conducting test and interpreting the results, and 
the environment in which the tests are stored and transported 
(ideally below 30oC).2
Three malaria parasite target antigens can be detected by 
MRDT technology: histidine-rich protein II (HRPII), which 
is found only in Plasmodium falciparum; and parasite lactate 
dehydrogenase (PLDH) and aldolase, present in all Plasmodium 
species.1 The HRPII antigen detection test is suitable for South 
Africa because species other than P. falciparum are very rare.3
The World Health Organization (WHO) guidelines 
recommend that for an MRDT to be deemed ‘accurate’ it 
should have a sensitivity of ≥95% and a specificity of ≥90% 
at a level of ≥100 parasites per µl of blood, compared with 
microscopy;2,4 and that microscopy is an acceptable gold 
standard provided that good techniques, good-quality 
reagents and – most importantly – well-trained and supervised 
microscopists are available.
Studies in Africa show variability in sensitivity and 
specificity of HRPII antigen detection tests.2,5 Field evaluations 
of MRDTs in South Africa are sparse; an evaluation of the 
accuracy of the ICT Malaria Pf card test (ICT Diagnostics, 
Sydney, Australia) in Mpumalanga province showed a 
sensitivity and specificity of 98.6% and 97.9% respectively.6 
Although the overall test accuracy was higher than the WHO 
acceptable threshold levels, the accuracy of this MRDT to 
detect parasitaemia of ≤100 parasites per µl of blood was not 
assessed.2
Owing to the variability in sensitivity and specificity of 
HRPII-based MRDTs in Africa, and the fact that the currently 
used ICT Pf MRDT (Global Diagnostics) was not robustly field-
tested in South Africa, we studied the field accuracy of this 
MRDT.
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Background. Malaria rapid diagnostic tests (MRDTs) are quick 
and easy to perform and useful for diagnosing malaria in 
primary health care settings. In South Africa most malaria 
infections are due to Plasmodium falciparum, and HRPII-based 
MRDTs have been used since 2001. Previous studies in Africa 
showed variability in sensitivity and specificity of HRPII-
based MRDTs; hence, we conducted a field evaluation in 
Limpopo province to determine the accuracy of the MRDT 
currently used in public sector clinics and hospitals.
Methods. A cross-sectional observational study was conducted 
to determine the sensitivity and specificity of an ICT Pf 
MRDT. We tested 405 patients with fever with ICT Pf MRDT 
and compared the results with blood film microscopy (the 
gold standard).
Results. The overall sensitivity of the ICT Pf MRDT was 
99.48% (95% confidence interval (CI) 96.17 - 100%), while 
specificity was 96.26% (95% CI 94.7 - 100%). The positive 
predictive value of the test was 98.48 (99% CI 98.41 - 100%), 
and the negative predictive value was 99.52% (95% CI 96.47 
– 100%).
Conclusions. The ICT Pf MRDT is an appropriate test to use 
in the field in South Africa where laboratory facilities are not 
available. It has a high degree of sensitivity and acceptable 
level of specificity in accordance with the World Health 
Organization criteria. However, sensitivity of MRDT at low 
levels of parasitaemia (<100 parasites/µl of blood) in field 
conditions must still be established.
S Afr Med J 2009; 99: 810-813.
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Methods
Our study was done during the high-transmission season 
(December 2006 - June 2007) in the Vhembe District, Limpopo 
Province, which borders southern Zimbabwe. This area was 
chosen because it had had the highest incidence of malaria in 
the province for the previous 9 years.
We estimated that 203 true malaria cases are needed to detect 
a 95% sensitivity with a 95% confidence limit of ±3%, assuming 
that 50% of suspected malaria cases are true malaria; we 
therefore enrolled 405 suspected malaria sufferers from 2 clinics 
for our cross-sectional study. The subjects were consecutively 
selected cases (male or female) of suspected malaria (defined as 
presentation with fever or headache or chills), attending study 
clinics for an initial visit and who consented to participate. 
Patients attending the study clinics for follow-up visits, 
severely ill patients needing referral, patients with an obvious 
non-malarial fever, and pregnant women were excluded.
Nurses were trained on slide preparation and RDT testing 
procedures (preparation and interpretation of results) before 
the study. Standard operating procedures for slide making and 
RDT testing were also posted in the study clinics. On repeat 
visits to the clinics, we reviewed the slide preparation and RDT 
testing.
A patient identification number (ID) was used to label the 
data collection forms, the MRDTs and the thin and thick blood 
smears. Nurses performed an MRDT and made thick and thin 
blood films from patients after obtaining written informed 
consent. Blood films were sent to two specialised trained 
malaria microscopists at the Limpopo Department of Health 
(Thulamela Health Center, Vhembe District) for staining and 
microscopy using standard techniques.7
The microscopists were blinded to the MRDT results and 
read the thin and thick blood films independently. When 
there was discordance between microscopists’ and MRDT 
results, a medical technologist based at Limpopo Department 
of Health Malaria reference centre who was highly skilled 
in malaria microscopy and was blinded to the MRDT and 
field microscopists’ readings read the slides, and this result 
was taken to be correct.5 Cohen’s Kappa statistic was used 
to determine microscopist reliability; a score of ≥0.8 was 
considered reliable.
The primary measures to assess the accuracy of MRDTs 
were sensitivity, specificity and positive and negative 
predictive values, using microscopy as the gold standard. 
Data were managed using EPI Data version 3.1 and analysed 
using STATA 8.1. Mean and standard deviations, or median 
and inter-quartile ranges, were used to describe continuous 
variables. The continuous variables of parasitaemia, age and 
temperature were transformed into categorical variables 
e.g. parasitaemia was grouped into three categories (≤500 
parasites/µl, 501 - 5 000 parasites/µl or >5 000 parasites/µl). 
Sensitivity and specificity were determined for detecting any 
level of parasitaemia and for each parasitaemia category (≤500, 
501 - 5 000, >5 000).
Ethical approval was obtained from the London School of 
Hygiene and Tropical Medicine (reference 5061, 22 November 
2006), the Limpopo Health and Social Welfare Development 
Research Committee (reference 4/2/2) and the University of 
Limpopo Research Ethics and Publications Committee (MR 
123/2006).
Results
The median subject age was 24.5 years (range 1 - 81), 
approximately 84% presented with headache, 47% presented 
with fever, and 29% presented with chills, and  56% were male 
(Table I).
The kappa statistic comparing the two field microscopists’ 
results was 0.95 (p<0.001), indicating good reliability. There 
were 19 (5%) discordant microscopy results between the first 
and the second microscopy readers, which were settled by 
the reference laboratory microscopist. Discordant microscopy 
results showed that 94% (18 of 19) of the first microscopist’s 
readings were false negatives and 6% (1 of 19) was false 
positive. Parasite counts were conducted in approximately 
52% (10 of 19) of the discordant results. Nine slides were 
poorly stained or prepared, and parasite counts could not 
be confirmed on them. Those slides that did have parasite 
counts showed high-level parasitaemias (range: 560 - >20 000 
parasites/µl of blood), implying that these were missed by the 
first microscopist.
Of the 405 patients tested, 198 (49%) were positive for 
malaria by ICT Pf, and 191 (47%) were positive by microscopy. 
Of the 191 positive for Pf on malaria microscopy, 190 were 
positive by ICT Pf test (p<0.001), representing 1 false-
negative result by MRDT that was not among those that 
Table I. Distribution of selected characteristics in the 
participants
Characteristic              N  N (%)
Age (yrs)
Range               396  1 - 81 (9*)
Median    24.5
Sex 
Male                399 225 (56)
Female     174 (44)
Temperature
Range               402 35 - 40oC
Median     37.5oC (3*)
Presence of fever               402 189  (47.01)
Presence of chills              394 114 (29)
Presence of sweating             394 112 (28)
Presence of headache             399 337 (84)
* = IQR.
The totals for individual variables of <405 were because of missing values.
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were discordant. Among the 214 patients negative on slide 
microscopy, 206 were negative by ICT Pf test, representing 8 
false-positive results by MRDT.
The overall sensitivity of the ICT Pf malaria test was 99.48% 
(95% confidence interval (CI) 96.17 - 100%; p<0.001); specificity 
was 96.26% (95% CI 94.7 - 100%; p<0.001), the positive 
predictive value of the test was 98.48 (99% CI 98.41 - 100.00%; 
p<0.001) and the negative predictive value was 99.52% (95% CI 
96.47 - 100; p<0.001). The J-index for the test was 0.98 (p<0.001) 
and the likelihood ratio test (LRT) was 24.75 (positive) and 0.01 
(negative) (Table II).
Parasite counts were determined only for 61 slides because 
thick films were not always correctly prepared by nursing 
staff. Furthermore, there was only one false-negative ICT Pf 
result, and therefore there were no substantial observations in 
this analysis. The median parasitaemia calculated among the 
61 slides was 25 680 parasites/µl of blood, ranging from 440 
to >20 000 parasites/µl. The sensitivity was 97.7% for all three 
categories of parasitaemia.
Discussion
The incidence of malaria (regardless of diagnostic method) 
was higher among males, despite the Vhembe district having 
more female residents. This incidence is probably because 
the manual labour performed by most males exposes them 
to mosquitoes, especially at dawn and dusk when mosquito 
vectors are active.8 The living conditions of many workers are 
also poor and not adequately protected by routine malaria 
control operations.
There was good agreement between slide readings by the 
two microscopists. However, the false-negative microscopy 
results of one microscopist are of concern. Sensitivity of 
microscopy is expected to decline with low-level parasitaemias, 
particularly when the parasite density is <100 parasites/µl.5,9 
However, in this study, most false-negative results by a 
microscopist had a parasitaemia >100 parasites/µl of blood, 
raising concerns about microscopy quality in the malaria-
affected areas of Limpopo province. Malaria microscopy 
proficiency testing surveys in South Africa have shown 
generally poor performance in public sector laboratories, 
with those in malaria transmission areas performing no better 
than elsewhere.10 Ongoing training of microscopists, followed 
by regular slide quality monitoring, should therefore be 
considered by Limpopo province health authorities.
The high (99.48%) overall sensitivity of the ICT Pf in this 
study is consistent with other ICT Pf studies.2,4 It was not 
possible to assess MRDT sensitivity at a parasite density of 
≤100 parasites/µl of blood because all 61 slides that had a 
parasite count had >100 parasites/µl of blood. An alternative 
approach to determining parasite detection levels by the ICT 
Pf MRDT is to use laboratory dilution of wild-type parasites, 
similar to that conducted by others.5 An evaluation of the ICT 
Pf MRDT for parasite detection limit, by the Medical Research 
Council (MRC) of South Africa, using the protocol of Craig 
et al.,11 showed that the ICT Pf test gave 100% sensitivity at 
a parasite density of 70 parasites/µl of blood. Although the 
serial dilution approach is not ideal for determining the MRDT 
parasite detection limit, this finding gives some indication of 
ICT Pf sensitivity and specificity at low parasite densities.
There was only one false-negative MRDT result in our 
study. Reasons for false-negative results include: reduced level 
of parasites in circulating blood;5,9 decreased antigenaemia 
post-treatment of patients; poor end-user interpretation of 
weak positive results; low levels of antigens at early stages of 
infection, with presence of only sexual stages of the parasites; 
a variant HRPII antigen, not captured by the monoclonal 
antibodies of the ICT Pf testing system; anti-HRPII-Pf antibody 
potentially blocked immuno-detection by the ICT Pf testing 
system; and the occurrence of antigen-accelerated HRPII 
antigen clearance. The only false-negative case had  
1 920 parasites/µl of blood and the patient had not taken an 
antimalairal drug before the MRDT test. Others have reported 
similar findings.5 While MRDT false-negative results were 
rare in our study, health workers should know that a negative 
result does not always rule out the likelihood of malaria. 
However, the possibility of false-negative MRDT results should 
not be used as an excuse to ignore the MRDT results while 
making treatment decisions. Patients with an MRDT-negative 
result need not be treated with an antimalarial, but should be 
followed up closely and re-examined if they do not improve 
clinically.
There were 8 false-positive ICT Pf results in our study, 
possibly because patients previously treated for malaria could 
still have had circulating antibodies, which can persist for 
Table II. Accuracy of ICT Pf MRDT
         Sensitivity              Specificity           PPV                       NPV                    LRT test
         (95% CI)      (95% CI) (95% CI)                (95% CI)          Accuracy*              J-index        Pos.    Neg.
ICT Pf MRDT        99.48       96.26  98.48               99.52       97.7%    0.98       24.75     0.01
P. falciparum        (96.17 - 100.00)      (94.7 - 100.00) (98.41 - 100.00)      (96.47 - 100.00) 
* Overall true accuracy is the proportion of all the tests that gave a correct result, calculated as (TP+TN)/total number of tests).
pos. = positive, neg. = negative; J-index = the overall measure of reliability of the diagnostic test which summarises both sensitivity and specificity. The J-index lies between 0 and 1 
– when the J-index approaches 1, the overall diagnostic ability of the test approaches the ideal level; LRT test = indicates the probability that a positive rapid test result implies disease. 
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weeks after treatment.5,9 This was unlikely in our study as 
patients who had had recent malaria or had recently been 
on malaria treatment were excluded. Other reasons for false-
positive MRDT results are nonspecific heterophile antibodies 
produced by recent fever episodes and rheumatoid factor, 
and the false-positive ICT Pf tests might have been due to 
problems with microscopy. A highly sensitive test such as the 
ICT Pf test will yield lower specificities, especially in patients 
with low parasitaemias.1 While expert microscopy can detect 
low-level parasitaemias (10 - 50 parasites/µl), microscopy of 
blood films in malaria-endemic areas often misses low-density 
parasitaemias.2,5,9 Our study had the main limitation of slide 
preparation by nurses not being ideal, despite training and 
repeat visits by the research team. A key challenge was that 
nursing staff rotated among the clinics and hospitals, and often 
new staff would be present.
The specificity of the test was 96.26%. The relatively lower 
specificity than sensitivity is similar to other findings.5 Having 
a relatively lower specificity which leads to over-diagnosis and 
over-treatment of non-malaria cases is considered less serious 
than having a lower sensitivity.2,5
Conclusions
The ICT Pf test is an appropriate test to use in the field, where 
laboratory facilities are not available. The test has a high degree 
of sensitivity and acceptable level of specificity in accordance 
with WHO criteria. However, this study could not measure the 
sensitivity of ICT pf to detect parasitaemia <100 parasites/µl of 
blood.
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